After the first line of defence fails, AIDS patients find the second line unaffordable, says Ketan Tanna
Shashikant Shetye cannot afford to die. His mother and grandmother depend on his income as coordinator at Safe Sailors’ Club, part of the Humsafar Trust. The 40-year-old AIDS patient also cannot afford the expensive second line of anti-retroviral drugs (ART). While the first line of ART treatment costs Rs 1,200 a month, the second line costs anywhere between Rs 15,000 and Rs 40,000.
“I know that my body is now resistant to the first line of drugs, which I have been taking for some years. I need to take the second line. But they cost the earth,†says Shetye, helplessly. He is losing time.
In the past six months, he has lost 20 kilos, and weighs only 54 now. He has been hospitalised four times with severe diarrhoea. His count of CD4 (a type of white blood cell) has reduced to 111 from 264 over the past three years. A count below 200 is AIDS. “I am running my home on my savings and what I earn now. I don’t know what the future holds for me and I don’t know when I will die,†he says.
Money adds to the helplessness at the testing stage itself. Barring two private clinics in Mumbai, no other institution has the expertise or the equipment to conduct such a test, which costs more than Rs 30,000.
Nearly 52 lakh Indians are infected with HIV and AIDS. The National AIDS Control Organisation (Naco) now intends to provide the first line of drugs to one lakh patients by early 2007. Doctors say this is not good enough. Very soon, a second line of treatment will have to be stocked up. Even for the healthier lot of AIDS patients, as the first line sometimes starts failing in a couple of years. This invariably happens when the patient has either been lax in taking the drugs or was prescribed the wrong dosage.
“This is a serious problem that we face in Maharashtra. I have come across hundreds of patients who have either been given the wrong combination or the wrong dosage of ART drugs by doctors,†says a worried Dr Alka Deshpande, head, department of medicine, J J Hospital.
She sifts through a huge file of prescriptions that show how some doctors have been either careless or had limited knowledge. “There is little or no prescription monitoring. Drug companies have their own agenda in pushing the drugs they manufacture. The combination of these two factors have hit the lives of many patients,†she says, sighing.
In April 2006, 32-year-old Ritesh Batra died in pain. An already tired Batra reached the J J Hospital in 2004 after taking the ART treatment for a while in his home state of Punjab. However, in May 2005, his body started showing resistance to the first line of drugs. His vision slowly blurred and opportunistic infections swooped down on him. Tests were conducted at a reputed clinic in France, and a second line of drugs was started privately. But, by then, he had developed a bad case of diarrhoea and his body could not take it anymore. His wife too was diagnosed with HIV, but she has a CD4 count of over 400 and is not under the ART treatment. Fortunately, their little daughter is not HIV positive. But one wonders what will happen to her later.
Ironically, the government’s AIDS programme that is replete with numbers does not have any hard statistics on what percentage of AIDS patients is resistant to the first line of drugs.
Sunil Jadhav, 31, died in June 2005. Little is known about his family, but he approached J J hospital in June 2004. Before he went to the hospital, he was on the two-drug first line treatment. Unfortunately, since he was not working, he took the required drugs as and when he could afford them. Later, when the government started the free ART programme at J J Hospital, he had a viral load count (the amount of HIV virus in the blood) of 1,79,638 and a CD4 count of 120. He was then given a third tablet as a part of the treatment, in addition to the two that he had been taking.
But within a few months, his body started showing drug resistance. His test was also done in France.
The second line, it seems, is not for the masses. Their bodies are meant to just give up one day. TNN
鮮豔色彩可堆疊出理想效果且妝感明亮。 https://skinac.com/tag/方便
高能聚焦量超聲波( HIFU )以物理性聚焦集中成一點， 快速穿透皮膚真皮及脂肪層面直達面部表淺肌肉腱膜系統( SMAS )層令其組織細胞分子高速磨擦 ， 瞬間升溫至60 -70 度，令整個表淺肌肉腱膜系統( SMAS )受熱收縮，形成熱固化區域， 令結綈組織同時拉緊，達到拉皮防皺及美容效果。SMAZ聚焦超聲波提供了最有效的HIFU能量收緊皮膚及刺激胶原蛋白新生，提升彈性，恢復更緊緻的皮膚和更年輕的美貌。 http://cosmedicbook.com/treatments/info/Restylane-透明質酸
搜尋引擎最佳化 http://www.bizonrails.com/
隨借隨還，提早還款無罰息。 居屋二按. 公屋貸款. 公屋二按. 居屋按揭. 服務: 公屋貸款, 居屋按揭, 公屋二按, 居屋二按. http://wealthlink.hk/?page_id=134
A-DERMA 艾芙美 【燕麥新葉寶貝系列】燕麥新葉寶貝溫和潤膚乳霜 PRIMALBA Gentle Cocoon Cream的商品介紹 UrCosme (＠cosme TAIWAN) 商品資訊 A-DERMA 艾芙美,燕麥新葉寶貝系列,燕麥新葉寶貝溫和潤膚乳霜 PRIMALBA Gentle Cocoon Cream https://cosmetic.wiki/tag/靈芝草
大部份曾經生育或經歷更年期的女性都會面臨私密深處及外觀鬆弛問題，不單會影響自信心和伴侶的親密體驗，更有機會造成容易積菌及尿滲等健康問題。全港首部 Venus Fiore閨密儀 RF射頻 私密緊緻療程 專門針對私密各處包括陰道、陰唇及陰阜的專用治療頭，全面改善鬆弛問題；每個治療頭均採用一次性即棄治療蓋，確保衛生。還有ATC自動控溫綜合系統，讓療程的治療溫度被有效監控，療程自然更安全、更有效達至預期效果。全港首部 Venus Fiore閨密儀 RF射頻 私密緊緻療程Venus Fiore集中為女性私密之處提供最到位的呵護，專注重整陰道健康、收緊鬆弛陰唇和改善陰阜肥大問題。關鍵在於Venus Concept的王牌─糅合多極射頻與磁力脈衝的(ＭP)2磁頻專利技術，發揮提升細胞活躍度、重塑同時增加膠原蛋白、刺激毛細血管新生等作用，達至調整陰道濕潤度、pH值的效果，更重要的是顯著改善陰道彈性，使其回復年輕狀態。 http://cosmedicbook.com/treatments/info/全港首部-Venus-Fiore閨密儀-RF射頻-私密緊緻療程
疤痕、痂皮、色素的分別等一些相關議題、似是而非或有爭議的事項的披露與討論。 https://skinac.com/tag/質酸
激光無創熱作用模式精準作用於陰道粘膜層、肌層，使陰道組織發生新生改變，修復由於順產而引起的損傷，解決一系列產後女性生殖系統常見問題。私密緊緻作用原理：刺激陰道粘膜固有層、粘膜肌層，使其膠原纖維、彈性纖維大量增生重塑；彈性纖維網修復，陰道收緊 SUI作用原理：恢復盆底正常解剖位置 陰道彈性纖維網得以修復，恢復到正常解剖位置避免了擠壓，牽拉尿道，使尿道角度恢復正常 盆底血供豐富，間接的使尿道括約肌得以修復進而停止漏尿或症狀減輕 私密敏感、潤滑作用原理：CO2微脈管作用，使血管重建、促進血液循環 血管活性腸肽（VIP）和神經肽Y(NPY) 表達增加，敏感度增加 血流量增加，陰道上皮細胞功能增加、陰道粘膜自分泌功能增強，潤滑度增加 http://cosmedicbook.com/treatments/info/撫平皺紋-BOTOX-肉毒桿菌素
100純礦物防曬，清爽隱形防護科技，適用於各類型膚質 100純礦物防曬，清爽隱形防護科技，適用於各類型膚質 https://cosmetic.wiki/tag/脂肪移植
倩碧全效眼霜，可解決眼部四周肌膚困擾，並持續強化眼部膠原蛋白，維持彈性及光滑明亮。配方通過眼科醫生測試 https://skinac.com/tag/金致
有關肉毒、肉毒副作用、肉毒除皺、表情怪異、表情肌、眉毛下垂、肌肉痙攣等一些詳細敘述或似是而非或有爭議的事項。 https://skinac.com/tag/水膜
KIEHL`S 契爾氏 【頭髮保養】茶樹油洗髮精 Tea Tree Oil Shampoo的商品介紹 KIEHL`S 契爾氏,頭髮保養,茶樹油洗髮精 Tea Tree Oil Shampoo https://cosmetic.wiki/tag/療程
ESCENTS 伊聖詩 【ESCENTS】青春之泉潤膚乳液 Rejuvenating Hand & Body Lotion的商品介紹 ESCENTS 伊聖詩,ESCENTS,青春之泉潤膚乳液 Rejuvenating Hand & Body Lotion https://cosmetic.wiki/tag/再生
TULIP HIFU療程屬非侵入性及非手術的緊膚修身治療，獲歐盟CE、韓國KFDA、GMP、ISO9001、ISO13485等認證，安全可靠。 Tulip的DUAL HIFU精細技術，對面部和眼部治療特別有效；另外，TULIP FB有的13mm及7mm STAMP蓋印式治HIFU治療頭設計，眼、面以外部位，同時具「造身」效果。TULIP【DUAL HIFU高能量聚焦超聲波平台】【特點】－ 非手術、非侵入性緊膚治療－ 適用於任何膚色肌膚－ 治療更精確、更安全－ 備有7mm及13mm治療頭，可收緊腹部、臀部、手臂等鬆弛肌膚 【治療目的】－ 緊緻肌膚－ 提升輪廓－ 減淡皺紋－ 重塑輪廓線條－ 嫩膚亮肌－ 提升下垂眼部－ 重塑身體線條 (用於7mm/13mm修身治療頭)－ 重點減少脂肪細胞 (用於7mm/13mm修身治療頭) http://cosmedicbook.com/treatments/info/VENUS-VIVA
GUERLAIN 嬌蘭 【藍金水合彈力系列】藍金水合水感BB霜SPF25PA++的商品介紹 GUERLAIN 嬌蘭,藍金水合彈力系列,藍金水合水感BB霜SPF25PA++ https://cosmetic.wiki/tags/美顏霜-高濃縮
Newcastle's new boys appeared to have settled in quickly as the squad trained ahead of Saturday's match against Wellington Phoenix. Emmanuel Riviere, Siem de Jong and Newcastle squad train ahead of Saturday's match against Wellington Phoenix https://bit.ly/2JCArSc
Paul Lambert will stay at Aston Villa after talks with American owner Randy Lerner in New York. Lambert’s position was uncertain with the club up for sale for £200million, but he will continue as manager while working under similar cash guidelines as before. Paul Lambert staying as Aston Villa boss after meeting Randy Lerner in America https://bit.ly/2S3sXus